Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dayasagar Rao Vala"'
Autor:
Avinash Lokre, Dayasagar Rao Vala
Publikováno v:
Journal of Indian College of Cardiology, Vol 11, Iss 2, Pp 44-49 (2021)
Externí odkaz:
https://doaj.org/article/40bf6ac542574d49a12d318b835a4387
Publikováno v:
Indian Heart Journal, Vol 70, Iss , Pp S36-S42 (2018)
Objective: Present paper describes trends in prevalence and control of cardiovascular risk factors and clinical outcomes at 5-years for CLARIFY Indian cohort compared with rest of the world (ROW). Method: CLARIFY is an international, prospective-obse
Externí odkaz:
https://doaj.org/article/6f6e6d3d46a84e769bf75fd847a71365
Autor:
Dayasagar Rao Vala, Lokanath Seepana
Publikováno v:
Indian Journal of Cardiovascular Disease in Women, Vol 5, Iss 01, Pp 76-86 (2020)
The auscultation of second heart sound reveals presence of the disease and its pathophysiology, conduction defects, ventricular function, and hemodynamics around the aortic and pulmonary valves. To understand the splitting of the second heart sound,
Autor:
Amar Patnaik, Dayasagar Rao Vala
Publikováno v:
Indian Journal of Cardiovascular Disease in Women, Vol 06, Iss 01, Pp 068-070 (2021)
Autor:
Rajesh Natuva, Dayasagar Rao Vala
Publikováno v:
Indian Heart Journal. 74:S100
Autor:
Dayasagar Rao Vala, Avinash Lokre
Publikováno v:
JOURNAL OF INDIAN COLLEGE OF CARDIOLOGY. 11:44
Autor:
Surekha Rani Hanumanth, Mohammad Kaleemullah Quraishi, Kalpana Bellary, Dwarkanath K. Murthy, Dayasagar Rao Vala
Publikováno v:
Journal of Indian College of Cardiology. 6:169-172
Coronary Artery Disease (CAD) has been a major health concern in the Asian Indian population affecting millions of families. The 9p21.3 chromosomal region has shown robust association with CAD in several ethnic populations. The 9p21.3 locus doubles t
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 70, Iss, Pp S36-S42 (2018)
Indian Heart Journal, Vol 70, Iss, Pp S36-S42 (2018)
Objective: Present paper describes trends in prevalence and control of cardiovascular risk factors and clinical outcomes at 5-years for CLARIFY Indian cohort compared with rest of the world (ROW). Method: CLARIFY is an international, prospective-obse